The proliferation index of specific bone marrow cell compartments from myelodysplastic syndromes is associated with the diagnostic and patient outcome.
Myelodysplastic syndromes (MDS) are clonal stem cell disorders which frequently show a hypercellular dysplastic bone marrow (BM) associated with inefficient hematopoiesis and peripheral cytopenias due to increased apoptosis and maturation blockades. Currently, little is known about the role of cell...
Guardado en:
Autores principales: | Sergio Matarraz, Cristina Teodosio, Carlos Fernandez, Manuel Albors, María Jara-Acevedo, Antonio López, María Gonzalez-Gonzalez, María Laura Gutierrez, Juan Flores-Montero, Carlos Cerveró, Marlies Pizarro-Perea, María Paz Garrastazul, Gonzalo Caballero, Oliver Gutierrez, Guy Daniel Mendez, Manuel González-Silva, Paula Laranjeira, Alberto Orfao |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8d16534208c346109b714cf3ec6d1c84 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Molecular Progression of Myeloproliferative and Myelodysplastic/Myeloproliferative Neoplasms: A Study on Sequential Bone Marrow Biopsies
por: Magdalena M. Brune, et al.
Publicado: (2021) -
Clonal evolution in myelodysplastic syndromes
por: Pedro da Silva-Coelho, et al.
Publicado: (2017) -
TP53 in Myelodysplastic Syndromes
por: Yan Jiang, et al.
Publicado: (2021) -
Whole-Exome Sequencing Reveals Recurrent but Heterogeneous Mutational Profiles in Sporadic WHO Grade 1 Meningiomas
por: María González-Tablas, et al.
Publicado: (2021) -
Managing myelodysplastic symptoms in elderly patients
por: R Ria, et al.
Publicado: (2009)